LentiPro26: novel stable cell lines for constitutive lentiviral vector production.

ABSTRACT: Lentiviral vectors (LVs) are excellent tools to promote gene transfer and stable gene expression. Their potential has been already demonstrated in gene therapy clinical trials for the treatment of diverse disorders. For large scale LV production, a stable producer system is desirable since it allows scalable and cost-effective viral productions, with increased reproducibility and safety. However, the development of stable systems has been challenging and time-consuming, being the selection of cells presenting high expression levels of Gag-Pro-Pol polyprotein and the cytotoxicity associated with some viral components, the main limitations. Hereby is described the establishment of a new LV producer cell line using a mutated less active viral protease to overcome potential cytotoxic limitatio

SUBMITTER: Tomas HA 

PROVIDER: S-EPMC5869598 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature